A key member of the team that developed bone marrow transplantation as a successful treatment for leukemia nearly half a century ago, Frederick Appelbaum, MD, was honored on Feb. 18 with a Lifetime Achievement Award from the American Society for Transplantation and Cellular Therapy at the organization’s annual meeting in Orlando, Florida.
Learn more about a Covid investigational vaccine developed by City of Hope and licensed to GeoVax Labs that has shown success in a Phase 1 clinical trial.
A team lead by Fred Hutch physician-scientist Dr. Marie Bleakley has shown it can dramatically reduce chronic GVHD, a common debilitating side effect of stem cell transplantation in leukemia patients, using magnets to remove “naïve T cells” from the mixture of blood cells from a donor that are to be transplanted into the patient.